Allergies News and Research

Latest Allergies News and Research

UC Davis launches two clinical trials to evaluate treatments for COVID-19

UC Davis Health has two clinical trials underway for hospitalized patients with severe COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2.

27 Mar 2020

Anteater-like animals are the missing link for coronavirus transmission between bats and humans

As scientists scramble to learn more about the SARS-CoV-2 coronavirus, two recent studies of the virus' genome reached controversial conclusions: namely, that snakes are intermediate hosts of the new virus, and that a key coronavirus protein shares "uncanny similarities" with an HIV-1 protein.

26 Mar 2020

Combination produces more proliferative, enduring central memory T cells for cellular therapy

Treating T cells harvested from a patient with a combination of an epigenetic drug and a cytokine while expanding the cells in the lab re-programs them into a stronger T cell type that persists longer than its comrades, researchers at The University of Texas MD Anderson Cancer Center report in Cancer Immunology Research, a journal of the American Association for Cancer Research.

25 Mar 2020

Presence of certain gut bacterium in mothers could protect babies from food allergies

Researchers have found that bacteria in a mother’s gut during pregnancy can protect the baby from developing food allergies.

25 Mar 2020

Clinical trial launched to investigate safety and efficacy of antiviral drug for COVID-19

Physician-scientists at four University of California Health medical centers -- UC San Diego Health, UC San Francisco, UC Irvine Health and UC Davis Health -- have begun recruiting participants for a Phase II clinical trial to investigate the safety and efficacy of treating adult patients with COVID-19 with remdesivir, an antiviral drug that has shown activity in animal models and human clinical trials of SARS-CoV, MERS-CoV, Ebola, Marburg and other viruses.

24 Mar 2020

Coronavirus remains for several hours to days on surfaces and in aerosols, study reveals

The virus that causes COVID-19 remains for several hours to days on surfaces and in aerosols, a new study published in the New England Journal of Medicine found.

22 Mar 2020

Public health leadership needed to direct COVID-19 response and communications

In the United States today, healthcare providers seem appropriately confused about present and future issues concerning coronavirus disease 2019 (COVID-19).

20 Mar 2020

Researchers highlight urgent need for public health leadership during COVID-19 pandemic

For decades, public health officials have directed the containment of emerging pandemics - perhaps most notably - the worldwide eradication of smallpox starting in the early to mid-1960s.

19 Mar 2020

Coronavirus can stay in the air for hours and surfaces for days – how to disinfect?

As COVID-19 (coronavirus) spreads across the globe, scientists have found the virus can persist in the air for hours and on surfaces for days.

19 Mar 2020

COVID-19 stable for several hours to days in aerosols and on surfaces

The virus that causes coronavirus disease 2019 (COVID-19) is stable for several hours to days in aerosols and on surfaces, according to a new study from National Institutes of Health, CDC, UCLA and Princeton University scientists The New England Journal of Medicine.

17 Mar 2020

Immunotherapy combination can shrink viral reservoir in HIV model

Stimulating immune cells with two cancer immunotherapies together can shrink the size of the viral "reservoir" in SIV-infected non-human primates treated with antiviral drugs, researchers have concluded.

16 Mar 2020

Breast milk may help protect preemies from developing sepsis

A component of breast milk may help protect premature babies from developing sepsis, a fast-moving, life-threatening condition triggered by infection.

16 Mar 2020

mRNA vaccine against novel coronavirus goes on a trial in Seattle

A clinical trial for a vaccine to protect against the novel coronavirus commenced this Monday in the U.S.. If successful, this could mean an end to the current global pandemic of COVID-19 infections, feel experts.

16 Mar 2020

Researchers engineer microparticles that show promise against transplant rejection

Inspired by a tactic cancer cells use to evade the immune system, University of Pittsburgh researchers have engineered tiny particles that can trick the body into accepting transplanted tissue as its own.

13 Mar 2020

Aspergillus molds induce asthma by first attacking the lung's protective barrier

University of Wisconsin-Madison researchers have identified a new way that common Aspergillus molds can induce asthma, by first attacking the protective tissue barrier deep in the lungs.

12 Mar 2020

Potential targets for immune responses to novel coronavirus identified

Within two months, SARS-CoV-2, a previously unknown coronavirus, has raced around globe, infecting over a 100,000 people with numbers continuing to rise quickly.

11 Mar 2020

Newer antiretroviral drugs may be the safest, most effective HIV treatment during pregnancy

The antiretroviral drugs dolutegravir and emtricitabine/tenofovir alafenamide fumarate (DTG+FTC/TAF) may comprise the safest and most effective HIV treatment regimen currently available during pregnancy, researchers announced today.

11 Mar 2020

Australia: Coronavirus spreads, drive-through testing, pop up clinics and $2.4 billion

Australia has seen an increase in coronavirus disease (COVID-19) cases, and this will continue for weeks despite strict border control measures, experts say. With 116 confirmed cases and thousands of people waiting to be tested, Australian hospitals could be overwhelmed by thousands of patients.

10 Mar 2020

Marinomed extends the range of Marinosolv applications

Marinomed Biotech AG has achieved promising results for further areas of application with its Marinosolv® technology platform in preclinical studies.

From Marinomed Biotech AG 10 Mar 2020

PrEP drug levels found to lower among pregnant African adolescent girls and young women

Among African adolescent girls and young women who took HIV pre-exposure prophylaxis (PrEP) daily, levels of the PrEP drug tenofovir were more than 30% lower in those who were pregnant than in those who had recently given birth.

9 Mar 2020

Allergies News and Research

Latest Allergies News and Research

UC Davis launches two clinical trials to evaluate treatments for COVID-19

Anteater-like animals are the missing link for coronavirus transmission between bats and humans

Combination produces more proliferative, enduring central memory T cells for cellular therapy

Presence of certain gut bacterium in mothers could protect babies from food allergies

Clinical trial launched to investigate safety and efficacy of antiviral drug for COVID-19

Coronavirus remains for several hours to days on surfaces and in aerosols, study reveals

Public health leadership needed to direct COVID-19 response and communications

Researchers highlight urgent need for public health leadership during COVID-19 pandemic

Coronavirus can stay in the air for hours and surfaces for days – how to disinfect?

COVID-19 stable for several hours to days in aerosols and on surfaces

Immunotherapy combination can shrink viral reservoir in HIV model

Breast milk may help protect preemies from developing sepsis

mRNA vaccine against novel coronavirus goes on a trial in Seattle

Researchers engineer microparticles that show promise against transplant rejection

Aspergillus molds induce asthma by first attacking the lung's protective barrier

Potential targets for immune responses to novel coronavirus identified

Newer antiretroviral drugs may be the safest, most effective HIV treatment during pregnancy

Australia: Coronavirus spreads, drive-through testing, pop up clinics and $2.4 billion

Marinomed extends the range of Marinosolv applications

PrEP drug levels found to lower among pregnant African adolescent girls and young women

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Allergies News and Research

Latest Allergies News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in